Neurological symptoms due to myopathy and peripheral neuropathy were frequently investigated and treated in patients with OPA1 and TWNK mutations despite their features of optic atrophy, ptosis and ophthalmoplegia constituting the predominant phenotype [3, 21]. This evidence concerns the gene OPA1 and ophthalmoplegia.